| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3298880 | Gastroenterology | 2009 | 11 Pages |
Abstract
These results illustrate the importance of viral fitness and infectivity as a major determinant of antiviral therapy resistance in patients. Understanding HBV mutant selection in vivo will help to optimize new anti-HBV therapeutic strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stéphanie Villet, Gaëtan Billioud, Christian Pichoud, Julie Lucifora, Olivier Hantz, Camille Sureau, Paul Dény, Fabien Zoulim,